Himalaya Nutravedics IPO GMP today is Rs 0. Investors can use this GMP along with price band and subscription status for a better IPO review.
Upcoming
SME IPO
HLNUTRAVEDICS
Himalaya Nutravedics IPO GMP & Subscription Status Today
Himalaya Nutravedics, established in 2022, manufactures and markets Ayurvedic and nutraceutical products — softgel capsules, tablets, medicated oils, and protein powders — from a WHO-GMP certified facility in Hyderabad. Revenue rose to ₹43.12 crores with a net profit of ₹7.39 crores in FY2026.
- Price Band
- ₹100.00 - ₹106.00
- Lot Size
- 1,200 Shares
- Bidding Closes
- 24 Sept 2026
- Listing Date
- 29 Sept 2026
Current GMP Status
₹0
+0% vs upper band
Est. Listing Gain
+0.00%
Last Trend
18 Sept 2026
Listing Price
Est. ₹106
Retail Entry
₹2,54,400
IPO Details
Complete IPO information
| Current GMP | ₹0 |
|---|---|
| Estimated Listing Gain | +0.00% |
| Price Band | ₹100.00 - ₹106.00 |
| Issue Price | Approx ₹106.00 Crores |
| Listing Price | Est. ₹106 |
| Lot Size | 1,200 Shares |
| Issue Type | SME |
| Registrar | Kfin Technologies Ltd. |
| Exchange | BSE SME |
| Retail Quota | TBA |
| Overall Subscription | TBA |
| Listing Date | 29 Sept 2026 |
| Minimum Investment | ₹2,54,400 |
Analysis
IPO Snapshot & Investor Takeaways
At the upper end of its price band, Himalaya Nutravedics is priced at ₹106 per share. With a minimum lot size of 1,200 shares, a retail investor applying for one lot would need approximately ₹2,54,400 to participate in this SME issue.
The latest recorded Grey Market Premium for Himalaya Nutravedics stands at ₹0, implying an estimated listing gain of around 0.00% over the issue price if it holds until listing. GMP reflects informal grey-market sentiment rather than a guaranteed outcome, and can change at any point until the day of listing.
SME IPOs list on the dedicated SME platform of BSE/NSE. They usually involve smaller issue sizes and a higher per-lot investment than Mainboard issues, with comparatively lower institutional participation.
Timeline
IPO roadmap at a glance
01
Bidding Opens Next
22 Sept 2026
02
Bidding Closes
24 Sept 2026
03
Allotment
25 Sept 2026
04
Listing
29 Sept 2026
Grey Market Premium
Daily GMP status
Trend chart builds up as more daily GMP snapshots are recorded.
| Date | GMP | Change | Gain |
|---|---|---|---|
| 18 Sept 2026 | ₹0.00 | - | 0.00% |
Swipe to see more →
Market Lot
Application size breakdown
| Category | Lots | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 Lot | 2,400 | ₹2,54,400 |
| Retail Maximum | 2 Lot | 2,400 | ₹2,54,400 |
| S-HNI Minimum | 3 Lot | 3,600 | ₹3,81,600 |
| S-HNI Maximum | 7 Lot | 8,400 | ₹8,90,400 |
| B-HNI Minimum | 8 Lot | 9,600 | ₹10,17,600 |
Swipe to see more →
Analysis
Himalaya Nutravedics IPO Details
The Himalaya Nutravedics IPO is a book-building issue proposed to be listed on the BSE SME platform. The issue comprises a fresh issue of approximately ₹26.50 Crores, with the IPO scheduled to open on September 22, 2026 and close on September 24, 2026.
| Particular | Details |
|---|---|
| IPO Open Date | September 22, 2026 |
| IPO Close Date | September 24, 2026 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹100 to ₹106 Per Share |
| Issue Size | Approx ₹26.50 Crores |
| Fresh Issue | Approx ₹26.50 Crores |
| Issue Type | Book-building Issue |
| IPO Listing | BSE SME |
| DRHP Draft Prospectus |
Note: The IPO details are based on the supplied Himalaya Nutravedics IPO information and may be subject to updates announced by the company or exchange.
Analysis
Himalaya Nutravedics IPO Reservation
The Himalaya Nutravedics IPO reservation is divided across qualified institutional buyers, non-institutional investors, and retail investors. The reserved portions indicate the percentage of the net issue available to each investor category.
| Investor Category | Share Offered | -% Shares |
|---|---|---|
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | – Shares | 50% |
| NII Shares Offered | – Shares | 15% |
| Retail Shares Offered | – Shares | 35% |
Note: The share quantities are currently shown as provided and may be updated when the final IPO reservation details are announced.
Analysis
Himalaya Nutravedics IPO Anchor Investors
The Himalaya Nutravedics IPO anchor investor details provide information on the anchor bidding schedule, shares offered, issue size allocated to anchor investors, and the applicable lock-in periods. The available details are presented below.
| Particular | Details |
|---|---|
| Anchor Bidding Date | 2026 |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| Lock-in period end date 50% shares (30 Days) | 2026 |
| Lock-in period end date 50% shares (90 Days) | 2026 |
Note: Anchor investor quantities and lock-in dates are shown as provided and may be updated with the final IPO announcement.
Analysis
Himalaya Nutravedics IPO Dates
The Himalaya Nutravedics IPO is scheduled to open on September 22, 2026 and close on September 24, 2026. The IPO allotment is expected to be finalized on September 25, followed by refunds and credit of shares to Demat accounts on September 28. The IPO listing is scheduled for September 29, 2026.
| Particular | Details |
|---|---|
| IPO Open Date | September 22, 2026 |
| IPO Close Date | September 24, 2026 |
| Basis of Allotment | September 25, 2026 |
| Refunds | September 28, 2026 |
| Credit to Demat Account | September 28, 2026 |
| IPO Listing Date | September 29, 2026 |
Note: IPO dates are based on the supplied Himalaya Nutravedics IPO schedule and may be subject to changes announced by the company or stock exchange.
Analysis
Himalaya Nutravedics Promoters and Holding Pattern
The promoters of Himalaya Nutravedics are Rohit Asawa, Divya Asawa, Chanda Asawa and Rama Raju Penmatsas. The holding pattern below shows the shareholding of the promoter group and other shareholders before and after the proposed IPO.
| Particular | Pre IPO Shares | Pre IPO % Shares | Post IPO Shares | Post IPO % Shares |
|---|---|---|---|---|
| Promoter and Promoter Group | 60,00,000 | 95.14% | – | 69.94% |
| Others* | 3,06,720 | 4.86% | – | 30.06% |
| Total | 63,06,720 | 100% | 88,06,720 | 100% |
Note: Post-IPO share quantities are shown as provided and may be updated in the final IPO documents.
Analysis
Himalaya Nutravedics IPO Objects of the Issue & Utilisation of Proceeds
The proceeds from the Himalaya Nutravedics IPO are proposed to be used primarily for strengthening the company's working capital position and supporting business development initiatives. A portion of the funds is also planned for digital marketing activities to support the company's growth objectives.
| Purpose | Crores |
|---|---|
| Funding Working Capital Requirements | ₹13.75 |
| Business Development and Digital Marketing Activities | ₹7.50 |
| General Corporate Purposes | ₹- |
Note: The utilisation of IPO proceeds is based on the supplied information and may be subject to changes in the final offer documents.
Analysis
Himalaya Nutravedics About Ipo
Founded in 2022, Himalaya Nutravedics is an Ayurvedic and nutraceutical manufacturing firm involved in the formulation, manufacturing, and marketing of Ayurvedic and nutraceutical products. Its product portfolio includes Softgel Capsules, Tablets, Medicated Oils, Liquid Orals, Hardgel Capsules, and Protein Powders across therapeutic categories such as digestive health, immunity, metabolic health, and pain management.
The firm sells its products under its own brands and also sells them through doctors, hospitals, clinics, pharmacists, or other healthcare professionals. The firm has expanded its portfolio across 17 states and one union territory in India. Moreover, its manufacturing facility is located at is located in Hyderabad, Telangana, and holds WHO-GMP certifications. Its competitive strengths are strong relationships with suppliers and customers and Integrated multi-dosage manufacturing capability.
Analysis
Himalaya Nutravedics IPO Company Financials
The financial performance of Himalaya Nutravedics shows the company's revenue, expenses, profit after tax (PAT), and assets for the financial years 2024 to 2026. The figures provide a view of the company's financial progress during the reported period.
| Period Ended | Revenue | Expense | PAT | Assets |
|---|---|---|---|---|
| 2024 | ₹14.43 | ₹13.83 | ₹0.43 | ₹6.09 |
| 2025 | ₹21.00 | ₹18.75 | ₹2.23 | ₹10.82 |
| 2026 | ₹43.12 | ₹35.64 | ₹7.39 | ₹24.42 |
Amount ₹ in Crores. Note: Financial figures are presented as provided for the respective periods.
Analysis
Himalaya Nutravedics IPO Valuation – FY2026
The Himalaya Nutravedics IPO valuation indicators provide a snapshot of the company's profitability, capital efficiency, earnings, and net asset position for FY2026. Key measures include ROE, ROCE, EBITDA margin, PAT margin, EPS, P/E ratio, RoNW, and NAV.
| KPI | Values |
|---|---|
| ROE | 63.87% |
| ROCE | 36.41% |
| EBITDA Margin | 18.82% |
| PAT Margin | 17.16% |
| Debt to equity ratio | 0.31 |
| Earning Per Share (EPS) | ₹12.05 (Basic) |
| Price/Earning P/E Ratio | N/A |
| Return on Net Worth (RoNW) | 45.12% |
| Net Asset Value (NAV) | ₹26.70 |
Note: The valuation figures are based on the supplied FY2026 Himalaya Nutravedics IPO data.
Analysis
Himalaya Nutravedics IPO Peer Group Comparison
The Himalaya Nutravedics IPO peer group comparison provides selected financial indicators of companies operating in a similar healthcare and pharmaceutical space. The table covers EPS, PE Ratio, Return on Net Worth (RoNW), NAV, and income for the identified peer companies.
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
|---|---|---|---|---|---|
| Jeena Sikho Lifecare Limited | 7.30 | 106.03 | 33.23% | 21.96 | 469.07 Cr. |
| Sandu Pharmaceuticals Limited | 1.83 | 21.34 | 5.03% | 36.34 | 69.93 Cr. |
Note: Peer group figures are presented as provided and are intended for reference when reviewing the Himalaya Nutravedics IPO.
Analysis
Himalaya Nutravedics IPO Lead Managers aka Merchant Bankers
- Nirbhay Capital Services Pvt. Ltd.
FAQ
Himalaya Nutravedics IPO FAQs
Himalaya Nutravedics IPO price band is Rs 100.00 to Rs 106.00. Check the latest issue price, lot size and GMP together before applying.
Himalaya Nutravedics IPO open date is 22 Sept 2026, close date is 24 Sept 2026, and listing date is 29 Sept 2026.
Himalaya Nutravedics IPO lot size is 1,200 shares. The minimum retail investment is Rs 2,54,400.
Himalaya Nutravedics is classified as a SME IPO. This helps investors quickly understand the issue category and exchange segment.
Himalaya Nutravedics IPO subscription status currently shows Subscription data is currently awaited.
Himalaya Nutravedics, established in 2022, manufactures and markets Ayurvedic and nutraceutical products — softgel capsules, tablets, medicated oils, and protein powders — from a WHO-GMP certified facility in Hyderabad. Revenue rose to ₹43.12 crores with a net profit of ₹7.39 crores in FY2026.
Himalaya Nutravedics IPO issue size is TBA and the expected allotment date is 25 Sept 2026.
Community discussion
Comments
Share a useful question or insight about Himalaya Nutravedics.
Leave a comment
Your email address will not be published. All comments and replies are reviewed before appearing.
Loading comments...